LEGN peer analysis
Legend Biotech (LEGN) against its competitors: price, today's move, 1-year return and market value side by side.
LEGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALLO Allogene Therapeutics | $1.09 | -7.63% | -12.10% | $407.68M |
| ATRA Atara Biotherapeutics | $8.48 | 5.87% | -39.62% | $80.40M |
| AUTL Autolus Therapeutics | $1.42 | -6.58% | -8.39% | $404.57M |
| CLLS Cellectis | $1.03 | -4.17% | -70.00% | $108.79M |
| CRBU Caribou Biosciences | $0.44 | 3.95% | -81.82% | – |
| DTIL Precision BioSciences | $6.95 | -1.56% | -14.83% | $194.87M |
| FATE Fate Therapeutics | $2.01 | -3.37% | 48.89% | $249.23M |
| IPSC Century Therapeutics | $1.48 | 0.68% | 153.82% | – |
| LYEL Lyell Immunopharma | $10.88 | -1.45% | -34.69% | – |
| RNAC Cartesian Therapeutics | $6.34 | -2.31% | -22.40% | – |
| LEGN Legend Biotech | $21.10 | -2.45% | -34.88% | $4.21B |
- LEGN's peers: ALLO (Allogene Therapeutics), ATRA (Atara Biotherapeutics), AUTL (Autolus Therapeutics), CLLS (Cellectis), CRBU (Caribou Biosciences), DTIL (Precision BioSciences), FATE (Fate Therapeutics), IPSC (Century Therapeutics).
Updated 2026-11-03 11:33 UTC